LUPETTI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 9.868
AS - Asia 4.799
EU - Europa 4.510
SA - Sud America 719
AF - Africa 148
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.061
Nazione #
US - Stati Uniti d'America 9.610
IT - Italia 1.825
SG - Singapore 1.542
CN - Cina 1.302
HK - Hong Kong 758
BR - Brasile 609
DE - Germania 556
SE - Svezia 490
VN - Vietnam 367
BG - Bulgaria 275
FR - Francia 239
GB - Regno Unito 237
FI - Finlandia 193
CA - Canada 186
TR - Turchia 166
KR - Corea 165
RU - Federazione Russa 162
UA - Ucraina 148
IN - India 122
JP - Giappone 116
NL - Olanda 85
AT - Austria 77
CH - Svizzera 62
CI - Costa d'Avorio 43
IQ - Iraq 39
BD - Bangladesh 37
PL - Polonia 37
BE - Belgio 33
AR - Argentina 32
MX - Messico 26
ES - Italia 24
SA - Arabia Saudita 22
ZA - Sudafrica 22
PK - Pakistan 21
EC - Ecuador 20
IE - Irlanda 18
MA - Marocco 18
ID - Indonesia 17
MY - Malesia 17
UZ - Uzbekistan 15
VE - Venezuela 15
CO - Colombia 13
EG - Egitto 13
CZ - Repubblica Ceca 11
NG - Nigeria 11
PH - Filippine 11
SN - Senegal 10
AU - Australia 9
PY - Paraguay 9
CL - Cile 8
IL - Israele 8
JM - Giamaica 8
KE - Kenya 8
PA - Panama 8
AE - Emirati Arabi Uniti 6
GR - Grecia 6
IR - Iran 6
AZ - Azerbaigian 5
BB - Barbados 5
CR - Costa Rica 5
JO - Giordania 5
KH - Cambogia 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
TN - Tunisia 5
EE - Estonia 4
EU - Europa 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
OM - Oman 4
PE - Perù 4
RS - Serbia 4
TH - Thailandia 4
TW - Taiwan 4
UY - Uruguay 4
BN - Brunei Darussalam 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KW - Kuwait 3
NI - Nicaragua 3
QA - Qatar 3
SV - El Salvador 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
NA - Namibia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
Totale 20.033
Città #
Ashburn 1.057
Singapore 883
Houston 783
Woodbridge 779
Hong Kong 741
Fairfield 718
Ann Arbor 674
Santa Clara 554
Chandler 507
San Jose 501
Dallas 415
Milan 318
Seattle 276
Sofia 274
Shanghai 272
Beijing 259
Wilmington 259
Serra 242
Cambridge 230
New York 202
Hefei 191
Jacksonville 170
Boardman 169
Seoul 163
Pisa 162
Los Angeles 160
Princeton 141
Council Bluffs 139
Munich 138
Ottawa 138
Frankfurt am Main 125
Lauterbourg 112
Lawrence 111
Medford 105
Tokyo 101
Bremen 98
Izmir 92
Nanjing 91
Des Moines 82
Rome 80
Ho Chi Minh City 79
Helsinki 76
Florence 69
London 64
Dearborn 60
Vienna 58
Dong Ket 57
Hanoi 57
Redondo Beach 50
São Paulo 50
Bern 47
Istanbul 45
Buffalo 44
Abidjan 43
San Diego 43
Lucca 42
Marseille 37
Nanchang 34
Washington 34
Jüchen 30
Warsaw 28
Brussels 23
Redwood City 23
Columbus 22
Pune 21
Kunming 20
Nuremberg 20
Ogden 20
The Dalles 20
Boulder 19
Phoenix 19
Rio de Janeiro 19
Turku 19
Boydton 18
Chicago 18
Shenyang 18
Changsha 17
Da Nang 17
San Francisco 17
Jiaxing 16
Dublin 15
Hebei 15
Hyderabad 15
Montreal 15
Baghdad 14
Guangzhou 14
Naples 14
Orem 14
Turin 14
Zurich 14
Belo Horizonte 13
Curitiba 13
Lancaster 13
Amsterdam 12
Atlanta 12
Brasília 12
Hangzhou 12
Livorno 12
Manchester 12
Tashkent 12
Totale 14.192
Nome #
Identification and Pathogenic Potential of Clinical Bacillus and Paenibacillus Isolates 364
Maternal anthropometric variables and clinical factors shape neonatal microbiome 340
Evaluation of a multiplex Real-Time PCR assay for the diagnosis of human intestinal protozoa in Azienda Ospedaliero Universitaria Pisana 327
Comparative evaluation of antimicrobial activity of different types of ionic liquids 272
Diagnosis of bloodstream infections by mass spectrometry : present and future 254
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 233
Direct inoculation of positive blood cultures using the Phoenix system for antimicrobial susceptibility testing of both Gram-positive and Gram-negative bacteria 220
Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy 214
CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis 207
Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes 206
Identification of Candida albicans karyotypes characterized by a high proteolytic activity. 205
Antimicrobial Activity of a New Aloe vera Formulation for the Hygiene of the Periocular Area 204
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 204
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 202
A comparison of skin storage methods for oculoplastic surgery 199
Anti-biofilm Activity of the synthetic peptide hLF 1-11 against different Candida species in Lumen Catheters. 198
Molecular basis of resistance to azole antifungals. 195
Comparative evaluation of six chromogenic media for presumptive yeast identification 193
Effects of Pseudomonas aeruginosa on immune functions. 190
Radiopharmaceuticals: new antimicrobial agents 190
99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus 190
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. 190
Antifungal effect of the antimicrobial peptide hLF(1-11) on invasive infections with Candida albicans. 189
Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice. 188
Pushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification 188
Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections 184
Recent advances in the microbiological diagnosis of bloodstream infections 183
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases 179
Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11 175
Saponin promotes rapid identification and antimicrobial susceptibility profiling of Gram-positive and Gram-negative bacteria in blood cultures with the Vitek 2 system 174
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert 173
Analysis of the microbial content of probiotic products commercialized worldwide and survivability in conditions mimicking the human gut environment 172
Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains 172
CORT0C04210 is required for Candida orthopsilosis adhesion to human buccal cells 172
Detection of fungal infections using radiolabeled antifungal agents 170
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area 170
Rapid and Accurate Identification of Nontuberculous Mycobacteria Directly from Positive Primary MGIT Cultures by MALDI-TOF MS 167
Radiotracers for fungal infection imaging 167
A new culture-based method for rapid identification of microorganisms in polymicrobial blood cultures by MALDI-TOF 164
From positive blood culture to microbiological diagnosis in 4 hours by MALDI-TOF mass spectrometry bacterial identification and rapid antibiogram. 163
Identification of Bacillus species: Implication on the quality of probiotic formulations 163
Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species 162
Candidacidal activities of human lactoferrin peptides derived from the N terminus 162
Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin 161
Human antimicrobial peptides’ antifungal activity against Aspergillus fumigatus 160
Technetium-99m labeled cationic antimicrobial peptides for infection detection and treatment monitoring 158
Reactivation of Graves' Orbitopathy after Rehabilitative Orbital Decompression 158
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains 157
Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin 156
Pulmonary sporotrichosis with hyphae in a human immunodeficiency virus-infected patient. A case report. 155
Graves’ orbitopathy presenting after botulinum toxin injections 154
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 154
Identification of Candida albicans karyotypes characterized by a high proteolytic activity 153
99mTc-Antimicrobial peptides: promising candidates for infection imaging 153
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg 153
Graves’ orbitopathy in a patient with adrenoleukodystrophy after bone marrow transplantation 153
The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters 153
A Rapid Procedure for Identification and Antifungal Susceptibility Testing of Yeasts From Positive Blood Cultures 153
Characterization of the chemotaxis fliY and cheA genes in Bacillus cereus 152
FlhF Is Required for Swarming Motility and Full Pathogenicity of Bacillus cereus 152
Synergistic activity between colistin and the ionic liquids 1-methyl-3 dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, or 1 dodecyl-1-methylpiperidinium bromide against Gram-negative bacteria 152
Control of Candida albicans murine vaginitis by topical administration of polycarbophil-econazole complex 151
Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections 150
Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41 150
Rapid and reliable identification of Gram-negative bacteria and Gram-positive cocci by deposition of bacteria harvested from blood cultures onto the MALDI-TOF plate. 150
Molecular monitoring of Candida albicans infections in liver transplant recipients 150
Radiochemical and biological characteristics of Technetium-99m labelled fluconazole 149
In vitro resistance and evolution of resistance to tavaborole in Trichophyton rubrum 148
Erratum to: Compositional Quality and Potential Gastrointestinal Behavior of Probiotic Products Commercialized in Italy (Frontiers in Medicine, (2018), 5, 10.3389/fmed.2018.00059) 146
Caratterizzazione genotipica di Candida albicans 146
Molecular targeted treatments for fungal infections: the role of drug combinations 146
A comparison for skin storage methods for oculoplastic surgery 146
MALDI-TOF MS Applications to the Detection of Antifungal Resistance: State of the Art and Future Perspectives 146
Role of cpals4790 and cpals0660 in candida parapsilosis virulence: evidence from a murine model of vaginal candidiasis 146
99mTc-labelled antimicrobial peptides for detection of bacterial and Candida albicans infections 145
Comparison of different microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fluid 143
Internal thiols and reactive oxygen species in the candidacidal activity exerted by a N-terminal peptide of human lactoferrin. 142
Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation 141
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 141
Anti-Staphylococcal Biofilm Effects of a Liposome-Based Formulation Containing Citrus Polyphenols 139
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species 139
Radiolabelled antimicrobial peptides for infection detection 139
Candida parapsilosis sensu stricto Antifungal Resistance Mechanisms and Associated Epidemiology 139
Spotlight on the Compositional Quality of Probiotic Formulations Marketed Worldwide 137
Proteolytic activity and SAP gene expression in Candida albicans strains having different karyotypes 136
Rapid identification and antibiotic susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 System 136
Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center 134
The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis 133
Comparison of molecular typing methods for Candida albicans strain delineation. 133
Anti-staphylococcal activity of a polyphenol-rich citrus extract: synergy with β-lactams and low proficiency to induce resistance 131
Imaging of infections with Candida albicans with 99mTc-labelled antimicrobial peptides and the antifungal agent fluconazole. 131
New rapid methods cannot replace the current method to diagnose bloodstream infections. 131
Rapid identification of nontuberculous mycobacteria directly from positive primary MGIT coltures by MALDI-TOF MS 131
Sensitization of KPC and NDM Klebsiella pneumoniae To Rifampicin by the Human Lactoferrin-Derived Peptide hLF1-11 129
Recent advances and ongoing challenges in the diagnosis of microbial infections by MALDI-TOF mass spectrometry 126
A new rapid method for direct antimicrobial susceptibility testing of bacteria from positive blood cultures 125
Letter to the Editor 124
Dissecting the role of the MS‐ring protein FliF in Bacillus cereus flagella‐related functions 124
Technetium-99m labelled antimicrobial peptides and anti-infectives for the detection of bacterial and Candida albicans infections. 121
Letter to the Editor 119
Totale 16.814
Categoria #
all - tutte 59.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.320


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 0 0 0 0 0 0 189
2021/20221.256 28 86 16 97 189 154 36 75 80 66 50 379
2022/20231.826 201 193 114 221 244 207 15 136 330 14 130 21
2023/20241.476 138 163 166 106 236 264 43 35 39 65 71 150
2024/20254.647 94 183 84 216 470 436 479 257 420 552 596 860
2025/20264.826 307 589 528 335 499 410 710 234 347 483 211 173
Totale 20.547